Cutler Group LP Guardant Health, Inc. Put Options Transaction History

Cutler Group LP

10 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2023 May 01, 2023	SELL	$22.92 - $33.76 $61,884 - $91,152	-2,700 Reduced 54.0%	2,300 $1,000
Q4 2022 Feb 07, 2023	SELL	$25.44 - $59.78 $170,448 - $400,526	-6,700 Reduced 57.26%	5,000 $20,000
Q3 2022 Oct 25, 2022	SELL	$43.66 - $61.0 $4,366 - $6,100	-100 Reduced 0.85%	11,700 $159,000
Q2 2022 Aug 04, 2022	SELL	$28.82 - $77.35 $193,094 - $518,244	-6,700 Reduced 36.22%	11,800 $330,000
Q1 2022 Apr 14, 2022	BUY	$48.25 - $100.49 $472,850 - $984,802	9,800 Added 112.64%	18,500 $126,000
Q4 2021 Jan 18, 2022	BUY	$88.71 - $120.43 $736,293 - $999,569	8,300 Added 2075.0%	8,700 $19,000
Q2 2020 Jul 22, 2020	SELL	$60.49 - $97.5 $6,049 - $9,750	-100 Reduced 20.0%	400 $1,000
Q1 2020 May 07, 2020	SELL	$59.04 - $88.81 $129,888 - $195,382	-2,200 Reduced 81.48%	500 $5,000
Q3 2019 Oct 28, 2019	BUY	$62.59 - $110.3 $118,921 - $209,570	1,900 Added 237.5%	2,700 $36,000
Q2 2019 Aug 09, 2019	BUY	$63.94 - $91.11 $51,152 - $72,888	800 New	800 $4,000

324

127M

844K

2.38M

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $4.83B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.